Holen Sie sich die Stockscreener-App
3.91
1.11%
-0.10
Schlusskurs vom Vortag:
$4.01
Offen:
$4.04
24-Stunden-Volumen:
74,339
Relative Volume:
0.14
Marktkapitalisierung:
$118.81K
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.44M
KGV:
-0.244
EPS:
-16.0242
Netto-Cashflow:
$-28.30M
1W Leistung:
-8.21%
1M Leistung:
-15.27%
6M Leistung:
-95.69%
1J Leistung:
-98.71%
1-Tages-Spanne:
$3.83
$4.04
1-Wochen-Bereich:
$3.71
$4.38
52-Wochen-Spanne:
$2.78
$332.00
Nucana Plc Adr Stock (NCNA) Company Profile
Vergleichen Sie NCNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
3.91 | 7.65M | 0 | -33.44M | -28.30M | -16.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.23 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.92 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.18 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.14 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-03-03 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-10-22 | Eingeleitet | Truist | Buy |
| 2020-07-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-23 | Eingeleitet | Citigroup | Buy |
| 2017-10-23 | Eingeleitet | Jefferies | Buy |
| 2017-10-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Nucana Plc Adr Aktie (NCNA) Neueste Nachrichten
NuCana compliant with all Nasdaq continued listing criteria - MSN
Rising Momentum in European ADRs: A Strategic Entry Point for US Investors - AInvest
NuCana regains Nasdaq compliance, extends cash runway into 2029 - Investing.com
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025 - GlobeNewswire Inc.
What recovery options are there for NuCana plc Depositary ReceiptJuly 2025 Update & Expert Curated Trade Ideas - Newser
How institutional ownership impacts NuCana plc Depositary Receipt stockWeekly Trade Recap & Accurate Trade Setup Notifications - Newser
Wall Street Today: Dow, Nasdaq, S&P 500 open flat as investors focus on China tariff deadline; Nvidia down 1.3% - Mint
NuCana plc ADR’s Shares Reel: -92.65% Quarterly Revenue Decline Amid 14.58M Market Cap - investchronicle.com
HEPS’s Stock Dilemma: D-MARKET Electronic Services & Trading ADR’s Market Performance and Outlook - investchronicle.com
NuCana plc Announces Change in American Depository Shares Ratio to Enhance Liquidity and Nasdaq Compliance - Quiver Quantitative
GIBO Holdings Ltd (NASDAQ: GIBO): Down -99.40% In 2025, Outlook Remains Negative - stocksregister.com
What is the dividend policy of NuCana plc Depositary Receipt stockTremendous gains - jammulinksnews.com
NuCana Stock Set to Reverse Split on Friday, August 8th (NASDAQ:NCNA) - Defense World
NuCana Cancels Series A Warrants Post-ATM Execution - The Globe and Mail
NuCana completes cancellation of all remaining Series A Warrants - Investing.com
NCNA’s Market Whiplash: -98.30% YTD Decline, -65.02% Plunge in 30 Days - investchronicle.com
NuCana Announces ADS Ratio Change to Enhance Liquidity - The Globe and Mail
NuCana (NCNA) Announces 1-for-200 Reverse ADS Split Effective Aug 8 2025 - Stock Titan
NuCana to implement 1:200 reverse ADS split to boost share price - Investing.com
Nucana Plc shares surge 45% in premarket after receiving Nasdaq delisting notice and strong industry performance. - AInvest
NuCana (NCNA) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
NCNA Gets Second Nasdaq Notice; Hearing to Delay Potential Delisting - Stock Titan
NuCana enters $100 million at-the-market sales agreement for ADS offering - Investing.com
NuCana CEO takes leave of absence due to health reasons - Investing.com
Market Insight: RxSight Inc (RXST)’s Notable Drop, Closing at 13.50 - DWinneX
The Future of NuCana plc ADR: Analyzing NCNA - investchronicle.com
nucana plc announces annual report release and upcoming agm - Investing.com India
NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year - Stock Titan
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
NuCana prices $7 million direct offering of ADSs and warrants - Investing.com
NuCana prices $7 million direct offering of ADSs and warrants By Investing.com - Investing.com India
New Outlook On NuCana plc ADR - Stocksregister
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Zacks Investment Research
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Yahoo Finance
NuCana secures new US patent for cancer treatment NUC-7738 - Investing.com
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance
NuCana stock downgraded by William Blair after halted cancer study - Investing.com
Nucana Plc Share Price (NCNA.US) - London South East
NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com
NuCana (NCNA) Stock Trends and Sentiment 2025 - MarketBeat
NuCana (NCNA) Stock Forecast and Price Target 2025 - MarketBeat
NuCana regains Nasdaq compliance with bid price rule - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha
NuCana plcADR (NCNA) Price Target Increased by 15.39% to 5.10 - Nasdaq
NuCana plc (NCNA) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
NuCana plc Sponsored ADR Earnings and Revenue – NASDAQ:NCNA - TradingView
Here's Why NuCana PLC Sponsored ADR (NCNA) is Poised for a Turnaround After Losing 26.5% in 4 Weeks - Yahoo Finance
Down 34.6% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Yahoo Finance
What is the current Price Target and Forecast for NuCana (NCNA) - Zacks Investment Research
Here's What NuCana plc's (NASDAQ:NCNA) Shareholder Ownership Structure Looks Like - Yahoo Finance
Finanzdaten der Nucana Plc Adr-Aktie (NCNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.26%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):